
Saventic Health is an AI-driven company focused on diagnosing rare diseases. They leverage Natural Language Processing (NLP) and Machine Learning (ML) classifiers to analyze electronic health records (EHRs), identifying potential rare diseases and providing a rationale for their findings. Their mission is to support market stakeholders in diagnosing patients with rare diseases for clinical trials, treatment, or patient monitoring. They offer two platforms: Saventic Med Platform for medical clinics and physicians, and Saventic Care Platform for patients. Saventic Health operates globally with a presence in Canada, USA, Germany, Poland, and Brazil. Their focus areas include blood and bone marrow diseases, metabolic disorders, immune system diseases, and cardiology. The diagnostic process for rare diseases on average takes about 5 years, with only 1 in 8 patients being diagnosed and treated, highlighting the significant need Saventic Health addresses.

Saventic Health is an AI-driven company focused on diagnosing rare diseases. They leverage Natural Language Processing (NLP) and Machine Learning (ML) classifiers to analyze electronic health records (EHRs), identifying potential rare diseases and providing a rationale for their findings. Their mission is to support market stakeholders in diagnosing patients with rare diseases for clinical trials, treatment, or patient monitoring. They offer two platforms: Saventic Med Platform for medical clinics and physicians, and Saventic Care Platform for patients. Saventic Health operates globally with a presence in Canada, USA, Germany, Poland, and Brazil. Their focus areas include blood and bone marrow diseases, metabolic disorders, immune system diseases, and cardiology. The diagnostic process for rare diseases on average takes about 5 years, with only 1 in 8 patients being diagnosed and treated, highlighting the significant need Saventic Health addresses.
What they do: AI/NLP software to identify patients with rare diseases from EHRs and patient data
Products: Saventic Med (EMR/hospital integration) and Saventic Care (patient-facing platform)
Founded: 2019
Geographic footprint: Operations/projects in Poland, Canada, USA, Germany, Brazil
Funding signal: Convertible note announced Dec 10, 2024; lead investor 4growth VC
Rare disease identification and diagnostic acceleration using AI applied to electronic health records and clinical data.
2019
Healthtech / Medtech
€1.9M
Bridge round led by 4growth VC with co-investment from NCBR Investment Fund ASI S.A. and TNI Fund
“Lead investor 4growth VC; co-investors include NCBR Investment Fund ASI S.A. and TNI Fund”